Related Experiment Video

Updated: May 15, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Titanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitro

Martin Rottman1, Joel Goldberg, S Adam Hacking

  • 1Laboratory for Musculoskeletal Research and Innovation, Department of Orthopaedics, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Plos One
|January 4, 2013
PubMed

Insights

Combining soluble rifampicin with vancomycin-tethered titanium effectively controls Staphylococcus aureus implant infections. This approach enhances rifampicin

Area of Science:

  • Biomedical Engineering
  • Infectious Diseases
  • Materials Science

Background:

  • Rifampicin is a potent antibiotic for Gram-positive implant infections.
  • Bacterial resistance to rifampicin necessitates combination therapies.
  • Developing strategies to overcome antibiotic resistance is crucial for effective infection control.

Purpose of the Study:

  • To evaluate the efficacy of soluble rifampicin combined with vancomycin-tethered titanium against Staphylococcus aureus in vitro.
  • To assess the potential of this combination therapy in preventing antibiotic resistance.

Main Methods:

  • Titanium discs were tethered with vancomycin.
  • The vancomycin-tethered discs were challenged with varying inocula of Staphylococcus aureus.
  • Bacterial growth and survival were assessed.
  • Minimum Inhibitory Concentration (MIC) of rifampicin in combination with tethered vancomycin was determined.
  • The emergence of rifampicin resistance was evaluated.

Main Results:

  • Vancomycin-tethered titanium inhibited bacterial growth for inocula up to 2x10⁶ CFU/disc.
  • The combination therapy demonstrated an enhanced inhibitory effect, lowering the MIC of rifampicin by one dilution.
  • Surface-tethered vancomycin successfully prevented the emergence of rifampicin-resistant populations.

Conclusions:

  • Soluble rifampicin combined with vancomycin-tethered titanium is effective in controlling Staphylococcus aureus.
  • This combination strategy shows promise in preventing the development of antibiotic resistance.
  • Tethering antibiotics to implant materials offers a viable approach for combating implant-related infections.

More Related Videos

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...